SII, the owner of Covid Sheid says 100 million vaccines had to be destroyed because of expiry dates.
CEO of the SERUM INSTITUTE OF INDIA (SII) told the press that the company stopped the production of the booster dose in December last year and at least 100 million doses had to be thrown away as they got expired. The firm had to stop production because there was not much demand for vaccines.
SII is the world’s largest vaccine maker, it bought COVID SHEID to life another version of a popular vaccine ASTRAZENCA’S. These vaccines have a nine-month life, ending in September this year. Covid shields account for 90% of doses in India.
According to a Federal Health Ministry Report, India has administered over two billion doses of Covid 19 vaccines. The data shared by them stated that more than 70% of the population of India has taken both doses.
On the 23rd annual General meeting of the Developing Countries Vaccine Manufacturers Network in Pune, CEO Adar Poonawalla addressed the media and said that people are now fed up with Covid and vaccines, but they might get interested in taking a flu shot every year alongside booster doses.
He also mentioned the flu shot concept in India that, unlike the West, India has not adopted the concept of taking flu shots every year.
PRIORITY OF BOOSTER DOSE VACCINES
India started giving booster doses in January 2022, mainly prioritizing first were healthcare and front-line workers and also people who are 60 years and above. Later on, the doses were also advised to be taken by another age group.
According to a report by Union Health Ministry, India has successfully administered 298 million booster doses.
In July, on the occasion of INDIA’S 75 years of Independence, the government announced the provision of free booster doses to all adults for 75 days.
Mr. Poonawalla stated that for booster doses, Covisheid vaccines are allowed to be mixed with other doses. He mentioned that “Now Covovax should be allowed to be mixed soon in two weeks, So I think they will and should probably have the policy to mix boosters. If WHO allowed it, then maybe the Indian regulator will and should allow it.
In the trials of Novavax’s COVID VACCINES COVOVAX, a booster shot has been completed and they are expecting approval in 10-15 days. They have also incorporated with Novavox, a US-based company to find out the possible booster of the current Omricone variant which is spreading fear in the country.
Not only this, at least 20000-30000 doses of Ebola Vaccines are sent By SII for trial purposes to World Health Organization (WHO). If the trial becomes successful, they might consider stocking these vaccines for a future outbreak.
 In Uganda, 50 confirmed cases of Ebola have been found and 19 deaths have been reported.
Â
Read more – A 12-YEAR-OLD GIRL’S MURDER CREATES OUTRAGE IN PARIS.